• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Ormat Technologies

Ormat Technologies

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology

    Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology

  2. ADRs End Lower; Vodafone Edges Down

    ADRs End Lower; Vodafone Edges Down

  3. Ormat Technologies' Moat Delivers Overseas

    Its business model, technological dominance, and much lower exposure to fossil fuel commodity prices set the firm apart from peers.

  4. KONE to Enrich Customer Experience with Orange Business Services Contact Center Solutions

    KONE to Enrich Customer Experience with Orange Business Services Contact Center Solutions

  5. The Wendy's Company Reports First-Quarter 2015 Results

    The Wendy's Company Reports First-Quarter 2015 Results

  6. Don’t Fight the Central Banks

    We are placing our fair value estimate for Ormat Technologies ORA under review as we transfer coverage to another analyst.

  7. Our Outlook for Utilities Stocks

    With interest rates rising, will dividend yields keep utilities afloat?

  8. Large Utilities Set to Outperform Smaller Peers

    Regulated utilities could be hit hard by inflation, while diversified firms have long-term value that the market refuses to recognize.

  9. Our Outlook for Utilities Stocks

    Final environmental regulations give utilities near-term certainty but no comfort.

  10. Our Outlook for Utilities Stocks

    Utilities show no signs of slowing down with yields that look as good as ever.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.